•  
  •  
 

Problems and perspectives in pharmaceutics and drug discovery

Abstract

he work provides the result of researches on an establishment of reliable characteristics of authentic-ity, good quality of local raw materials jerusalim sage and the necessity of its standardizations with the purpose of advancement in medical practice.Key words:herba Phlomis thapsoides, flavonoids, humidity, the organic impurity that is insoluble in 10% solution of hydrochloric acid, mineral,impurity, microbiological purity.

First Page

46

Last Page

49

References

1.Opredelitel rasteniy Sredney Azii. Kritericheskiy konspekt florû, Tashkent, Izdatelstvo "Fan", -1993, - T.10, - S. 615. 2. Flora Uzbekistana. Tashkent, - 1962, - T.6, - S. 195-197. 3. Raxmankulov U., Kasimov Sh.Z., Tayjanov K., Sidyakin G.P. Nalichiye ?-laktonov u vidov sem. Asteraceae flori Sredney Azii // Rast. resursi. - 1979. - T.15, - Vip.1, - S. 79-89. 4.Perfilova V.N., Dyakov A.A., Tyurenkov I.N. Kardioprotektivnoye deystviye ferulovoy kislotû pri stressornom povrejdenii serdsa // Eksperim. i klinich. farmakologiya. - 2005. - T. 68, - 5. - S.19-22. 5. Xramov V.A., Dmitriyenko N.V. Xlorogenovaya kislota v listyax i liofilizirovannûxekstraktax stevii // Xim.- farmats. jurn. - 2000. - T.34, - 11. - S.34-35. 6. Hou Y.Z. et al.Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II // Eur. J. Pharmacol. - 2004. - Vol. 199, - 1. - P. 85-90. 7. Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin // Mini. Rev. Med. Chem., - 2009. - Vol. 9 (1), - P. 31-59. 8. Theoharides T.C., Kempuraj D., Iliopoulou B.P. Mast cells, T cells and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis // Adv. Exp. Med. Biol., - 2007. - Vol. 601, - P. 423-430. 9. . Popova N.V., Dixtyarev S.I., Maslova N.F., Litvinenko V.I., Almakayeva L.G., Lecheniye zabolevaniy pochek fitoximicheskimi preparatami // Ftoterapya. Chasopis, - 2011. - 4, - C. 40-44. 10. Ahn J., Lee H., Kim S., Park J., Ha T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways // Biochem. Biophys. Res. Commun., - 2008, - Vol. 373, - P. 545-549. 11. Kleemann R., Verschuren L., Morrison M., Zadelaar S., van Erk, M. J.,Wielinga, P. Y., Kooistra, T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vivo models // Atherosclerosis, - 2011, - Vol. 218. - P. 44-52. 12. Gibellini L., Pinti M., Nasi M., Montagna J.P., De Biasi S., Roat E., Bertoncelli L., Cooper E.L., Cossarizza A. Quercetin and cancer chemoprevention // Evid. Based. Complement Alternat. Med., - 2011. doi: 10.1093/ecam/neq053. 13. Staedler D., Idrizi E., Kenzaoui B.H., Juillerat-Jeanneret L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells // Cancer Chemother. Pharmacol., - 2011, - Vol. 68, - P. 1161-1172.

Share

COinS